New Assays: Total Infliximab ELISA and Infliximab ELISA for measurement
in serum or plasma.
Nashua, NH April 25, 2016: Eagle Biosciences today announced the launch
of two new assays, Total
Infliximab ELISA , Infliximab
ELISA and Golimumab
(Simponi ®) ELISA Assay Kit. These
assays were developed and manufactured by Tani Medikal in its ISO 9001 and ISO
13485 certified production site. Tani
Medikal offers a variety of products for in
vitro Diagnostics, medical devices, and medical equipment.
“Eagle is not only excited for this new partnership with Tani
Medikal but also eager to bring on more unique products like the Total
Infliximab ELISA , Infliximab
ELISA and Golimumab
ELISA assays. “said Dan Keefe, President of Eagle Biosciences. He continued, “These assays come from a new
comprehensive line of Drug & Anti-Drug ELISA kits, also known as
ImmunoGuide. All of these assays are sensitive,
fast, and require small sample volume.”
This product is currently for research use only. Check out the links below, visit the EagleBio
website, www.EagleBio.com,
or call 866-411-8023 for full details.
Related Products:
Infliximab
(Remicade®) ELISA (mAb-based) Assay Kit
Infliximab
(Remicade®) Antibodies ELISA Assay Kit